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Abstract
Background: Nonalcoholic fatty liver disease is the most common chronic liver disease in the world, and is
becoming increasingly prevalent. Saponins of sea cucumber (SSC) are proven to exhibit various biological activities.
Therefore, the present study was undertaken to examine the effect of saponins extracted from sea cucumber
(Pearsonothuria graeffei) on the preventive activity of fatty liver in rats.
Methods: Male Wistar rats were randomly divided into five groups, including normal control group, fatty liver
model group, SSC-treated group with SSC at levels of 0.01%, 0.03% and 0.05%. Model rats were established by
administration with 1% orotic acid (OA). After the experiment period, serum total cholesterol (TC), triglyceride (TG),
and hepatic lipid concentrations were determined. To search for a possible mechanism, we examined the changes
of key enzymes and transcriptional factors involved in hepatic lipids biosynthesis, fatty acid b-oxidation.
Results: Both 0.03% and 0.05% SSC treatment alleviated hepatic steatosis and reduced serum TG and TC
concentration significantly in OA fed rats. Hepatic lipogenic enzymes, such as fatty acid synthase (FAS), malic
enzyme (ME), and glucose-6-phosphate dehydrogenase (G6PDH) activities were inhibited by SSC treatment. SSC
also decreased the gene expression of FAS, ME, G6PDH and sterol-regulatory element binding protein (SREBP-1c).
Otherwise, the rats feeding with SSC showed increased carnitine palmitoyl transferase (CPT) activity in the liver.
Hepatic peroxisome proliferator-activated receptor (PPARa), together with its target gene CPT and acyl-CoA oxidase
(ACO) mRNA expression were also upregulated by SSC.
Conclusions: According to our study, the lipids-lowering effect of dietary SSC may be partly associated with the
enhancement of b-oxidation via PPARa activation. In addition, the inhibited SREBP-1c- mediated lipogenesis
caused by SSC may also contribute to alleviating fatty liver.
Background
Nonalcoholic fatty liver disease (NAFLD) evolves when
large amounts of lipids deposit in the hepatocytes with
no excessive alcohol consumption [1]. Population stu-
dies show that NAFLD is strongly associated with the
clinical features of the metabolic syndrome such as obe-
sity [2,3], type II diabetes [4], and dislipidemia [5]. The
etiological association between NAFLD and metabolic
syndrome has been shown in both obese and non-obese
patients, and this leads to the suggestion that NAFLD is
the liver manifestation of metabolic syndrome [6].
NAFLD is the most common liver disease in western
countries, and it is becoming increasingly prevalent in
Asian-Pacific regions because of the increasing westerni-
zation lifestyle [7]. According to Angulo’s review,
NAFLD affects 10 to 24 percent of the general popula-
tion in various countries, and it is increasingly diagnosed
in children and adolescents [8]. Therefore more and
more researchers focus on the prevention or therapy on
NAFLD.
There is growing evidence that dietary sea cucumber
could improve lipids metabolism in rats [9,10]. Sea
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cucumber, is a traditional seafood and important medi-
cal material in Asian countries, rich in various bioactive
substance. Saponin (also called triterpene glycoside), is
the most important secondary metabolite and bioactive
composition of sea cucumber, which has been proven to
exhibit various biological activities, such as including
antifungal, anti-angiogenesis, anti-tumor and immuno-
modulatory effects [11-13]. However it is unknown
whether saponins of sea cucumber (SSC) may improve
lipid metabolism in animal models. Several lines of evi-
dence indicate that orotic acid (OA) administration
induces fatty liver [14,15]. It may therefore be useful as
an animal model for deeper understanding of biochem-
ical changes that occurs during the development of
NAFLD.
The aim of this work is to assess the effects of SSC
on preventing hepatic lipid accumulation in OA-
induced NAFLD rats. To investigate the possible
mechanism, we examined the key enzymes activities
related in fatty acid biosynthesis and b-oxidation. To
gain further insights into the molecule mechanism by
which SSC alters gene expression of hepatic lipids meta-
bolism, sterol-regulatory element binding protein
(SREBP-1c) mRNA, the principal regulator of hepatic
fatty acid biosynthesis, was determined. Meanwhile, the
mRNA expression of its response genes, FAS, ME and
G6PDH, were also determined. Besides the genes
involved in fatty acid de novo synthesis, the genes
involved in fatty acid b-oxidation, like PPARa and its
target genes, CPT and ACO, were also measured in this
study.
Materials and methods
Preparation of saponins from sea cucumber
Saponins were isolated from the sea cucumber, Pearso-
nothuria graeffei. Air-dried body walls (500 g) of Pearso-
nothuria graeffei were grinded into powder and
extracted four times with refluxing ethanol. The com-
bined extracts were evaporated in vacuo and further
partitioned between water and chloroform. The water
layer was extracted with n-butanol and the organic layer
was evaporated in vacuo to yield n-butanol extracts. The
n-butanol extracts were concentrated, and the extracted
residue was dissolved in water. Samples were applied
with a HP20 resin column, eluted with water, 80% etha-
nol and 100% ethanol in sequence. The fraction eluted
with 80% ethanol was collected and evaporated, which is
crude saponin with a final weight of 51.8 g.
Animals and diets
All aspects of the experiment were conducted according
to guidelines provided by the ethical committee of
experimental animal care at Ocean University of China
(OUC, China).
Male Wistar rats aged 5 wk were purchased from
Vital River (Beijing, China), weighting 130-140 g. The
rats were housed individually all through the feeding
experiment, in a room maintained at a 12 h light/dark
cycle, a constant temperature of 24°C and relative
humidity of 65 ± 15%. After a 5-day adaptation period,
rats were randomly divided into five groups consisting
of seven rats each with similar mean body weight (120 ±
2 g). Rats were assigned to the following five groups: 1) a
control group (Con) fed AIN-93G diet; 2) a model group
(OA) fed AIN-93G diet but containing 1% OA; 3) a
group (OA+0.01%) fed the diet containing but containing
1% OA plus 0.01% SSC; 4) a group (OA+0.03%) fed the
diet containing but containing 1% OA plus 0.03% SSC; 5)
a group (OA+0.05%) fed the diet containing but contain-
ing 1% OA plus 0.05% SSC. Experimental diets were pre-
pared according to recommendations of the American
Institute of Nutrition (AIN). The diet composition and
SSC concentration of the experimental diets were sum-
marized in Table 1. All rats had free access to water and
food for 10 days. At the end of the feeding period, rats
were killed by bleeding from the abdominal aorta under
diethyl ether anesthesia after overnight fasting. Serum
was separated from whole blood by centrifugation at
1500 g for 10 min at 4°C. Liver, perirenal adipose and
epidymal adipose were quickly excised, washed with ice-
cold isotonic saline. After excess water on the surface
was removed by blotting with filter paper, the tissues
were weighed, frozen in liquid nitrogen and stored at
-80°C until analysis.
Serum and liver lipids determination
Serum TG and TC concentrations were determined
using enzymatic reagent kits from Biosino (Beijing,
China) according to the manufacturer’s instructions.
Hepatic lipids were extracted with chloroform-methanol
2:1 as Folch et al. described [16], and then dissolved
Table 1 Compositions of experimental diets (g/kg diet)
Con OA OA+0.01% OA+0.03% OA+0.05%
Casein 200 200 200 200 200
Cornstarch 500 490 489.9 489.7 489.5
Sucrose 100 100 100 100 100
Corn oil 100 100 100 100 100
Mineral mix 35 35 35 35 35
Vitamin mix 10 10 10 10 10
Choline bitartrate 2 2 2 2 2
Cellulose 50 50 50 50 50
DL-Methionine 3 3 3 3 3
OA – 10 10 10 10
SSC – – 0.1 0.3 0.5
Vitamin mixture (AIN-93VX; Dyets Inc.)
Mineral mixture (AIN-93G; Dyets Inc.)
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using Triton X-100. TG and TC concentrations in liver
were determined using enzymatic reagent kits (Biosino,
China), and hepatic phospholipids levels were measured
by the methods of Bartlett [17].
Preparation of liver subcellular fractions
A piece of liver was homogenized in 6 vol of a 0.25-M
sucrose solution containing 1 mM of EDTA in 10 mM
of Tris-HCl buffer (pH 7.4). After precipitating the
nuclei fraction, the supernatant was centrifuged at
10 000 g for 10 min at 4°C to obtain mitochondria. The
resulting supernatant was recentrifuged at 125 000 g for
60 min to precipitate microsomal, and the remaining
supernatant was used as the cytosol fraction. The micro-
somal pellet was resuspended in a 0.25 M of sucrose
solution as described above. Protein concentration was
determined by the method of Lowry et al. [18], with
bovine serum albumin used as the standard.
Assays of hepatic enzyme activity
The enzyme activity of fatty acid synthase (FAS;
EC2.3.1.85) was determined according to the procedure
described by Ikeda [19]. The reaction solution contained
0.1 M of phosphate buffer (pH 7.0), 0.2 M of EDTA,
50 μM of acetyl coenzyme A (CoA) and 0.3 mM of
reduced nicotinamide adenine dinucleotide phosphate.
The entire solution was equilibrated at 30°C. The reac-
tion was initiated by the addition of 0.8 mL cytosol frac-
tion and absorbance was monitored for 2 min at 340
nm. The malonyl-CoA-dependent rate was monitored
for 3 min.
The enzyme activity of malic enzyme (ME; EC1.1.1.40)
was determined as Ochoa described previously [20]. The
reaction solution contained 64 mM of triethanolamine
hydrochloride (pH 7.4), 1.2 mM of malic acid, 1.2 mM
of oxidized nicotinamide adenine dinucleotide phos-
phate, and 4 mM of MnCl2. The reaction was initiated
by the addition of 0.6 to 0.8 mg of a protein source
(cytosol) in a final assay volume of 1 mL at 27°C and
absorbance was monitored at 340 nm for 2 min.
The enzyme activity of glucose-6-phosphate dehydro-
genase (G6PDH; EC1.1.1.49) was assayed using the
method of Glock [21]. The reaction solution contained
0.16 M of Tris-HCl buffer (pH 7.6), 30 mM of MgCl2,
3.3 mM of glucose-6-phosphate, 1.6 mM of oxidized
nicotinamide adenine dinucleotide phosphate, and 1 U
of 6-phosphogluconate dehydrogenase. The reaction was
initiated by the addition of 0.3 to 0.4 mg of a protein
source (cytosol) in a final assay volume of 1 mL at 30°C
and the absorbance was monitored at 340 nm for 2 min.
The enzyme activity of carnitine palmitoyl transferase
(CPT; EC2.3.1.23) was determined as described pre-
viously [19]. The reaction solution contained 58 mM of
Tris-HCl buffer (pH 8.0), 1.25 mM of EDTA, 1.25 mM
of L-carnitine, 0.25 mM of 5,5’-dithiobis-2-nitrobenzoic
acid, 37.5 μM of palmitoyl-CoA, and 0.1% Triton-X.
The entire solution was equilibrated at 27°C. The reac-
tion was initiated by the addition of 0.2 mL mitochondri
fraction and absorbance was monitored for 5 min at 412
nm. The L-carnitine-independent rate was monitored
for 5 min. The difference between with and without
L-carnitine gave the L-carnitine-dependent rate for for-
mation of CoA-SH.
Analysis of mRNA expression of hepatic genes
For analysis of gene expression, total RNA was extracted
from 100 mg frozen liver samples using Trizol reagent
(Invitrogen, USA). RNA was quantified by A260 and its
integrity verified by agarose gel electrophoresis using
ethidium bromide for visualization. 1 μg total RNA and
random primer (TOYOBO, Japan) were used for cDNA
synthesis.
The concentration of cDNA was analyzed by real-time
detection PCR (ABI Prism 7500 Sequence Detection
System, USA) using Sybr Green I Master Mix
(TOYOBO, Japan). PCR was carried out with a final
volume of 30 μL reaction mixture containing: 15 μL
master mix, 2 μL first-strand cDNA, 1 μL primer with
each forward and reverse, and H2O to make up 30 μL.
A dilution curve from one cDNA source using dilutions
of 1:2, 1:4, 1:8 and a no-template control was run for
each gene. The gene expression was determined by rela-
tive quantification using the standard curve method.
A final melting curve guaranteed the authenticity of the
target product. The expression signal of the housekeep-
ing gene b-actin served as an internal control for
normalization.
The primer sequences used for real-time PCR were as
follows (Table 2):
Statistical analyses
All statistical analyses were performed using PC SAS
software. One-way ANOVA and Tukey’s post hoc test
with least significant difference were used to compare
group means. Homogeneity of variances was tested by
Levene’s test and Welch’s ANOVA was used to compare
group means when the group variances were unequal.
All the values in tables and figures are expressed as




The initial body weight was similar in five groups (data
not shown). After 10 days experiment, there is no differ-
ence in daily food intake among any group. OA feeding
did not affect body weight, whereas the body weight was
slightly decreased by dietary SSC. The rats feed with
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OA resulted in a marked decrease in epididymal adipose
weight (P < 0.05) and had no change in perirenal adi-
pose tissue weight. Whereas 0.05% SSC treatment signif-
icantly reduced perirenal adipose weight in OA-fed rats
(P < 0.05). OA treatment significantly increased liver
weight compared with the control group (P < 0.01),
indicating lipids accumulation in the liver. Whereas SSC
did not affect liver weight in the OA-fed rats (Table 3).
Serum and hepatic lipids levels
Compared with control group, administration of OA
increased serum TG (P < 0.01) and TC concentration.
All dose SSC treatment groups tended to have lower
serum lipids than that of OA group, both 0.03% and
0.05% SSC showed significant lipid lowering effects on
both serum TG (P < 0.05, P < 0.01) and TC (P < 0.01,
P < 0.01) (Table 4).
Rats fed the OA diet had a hepatic TG concentration
about seven times higher than that in control group
(P < 0.01). However, dietary SSC attenuated liver TG
accumulation in all dose treatment compared with the
OA group (P < 0.05, P < 0.01, P < 0.01). In addition, the
same trend of hepatic TC concentration was observed
with TG between control group and OA group (P <
0.01); dietary SSC at 0.03% and 0.05% reduced hepatic
TC content (P < 0.01, P < 0.05). Whereas, there was no
difference in hepatic phospholipids content among these
groups (Table 4).
Hepatic enzyme activities involved in lipids biosynthesis
We examined the activities of critical enzymes in the
liver involved in lipids biosynthesis, including FAS, ME
and G6PDH. Considering the integrated lipids lowering
effects of SSC, we chose 0.05% SSC treated group to
access the changes of those enzymes because it exhib-
ited most effective actions. After fed with OA diets for
10 days, the rats showed a significantly increased activity
of enzymes all above compared with rats fed normal
AIN-93 diet (P < 0.01, P < 0.05, P < 0.05), implying an
enhancement of lipogenesis in liver. When giving 0.05%
SSC to NAFLD rats, hepatic FAS, ME and G6PDH
activities tended to normal level, with a reduction of
41.2% (P < 0.01), 23.8% (P < 0.05) and 23.0% (P < 0.05)
separately compared with OA rats (Figure 1).
Hepatic enzyme activities involved in fatty acid
b-oxidation
The mitochondrial fatty acid b-oxidation in liver was
suppressed after OA administration (P < 0.05), as mea-
sured using hepatic CPT activity. Furthermore, a signifi-
cant increased CPT activity was observed in OA+0.05%
SSC group (P < 0.01), even higher than that of control
group (Figure 2).
Relative mRNA concentrations of SREBP-1c and its
target genesin the liver
To explore the molecular mechanism by which SSC may
regulate the different transcription factors and enzymes
related in lipids metabolism, we examined the expres-
sion of hepatic genes that regulate lipogenesis. 1% OA
administration markedly increased the expression of
hepatic SREBP-1c mRNA (P < 0.01) and also the target
lipogenic gene. OA caused a 1.4-fold induction of FAS
Table 2 Primers used in this study

































Gene-specific primers were designed by Primer Premier 5.0 software.
Table 3 The effect of SSC on body weight, food intake, adipose weight and liver weight in rats
Con OA OA+0.01% OA+0.03% OA+0.05%
Body weight, g 198.33 ± 6.76 199.71 ± 5.53 195.15 ± 4.74 196.00 ± 6.24 193.00 ± 7.93
Food intake, g/d 21.42 ± 0.90 20.77 ± 1.07 21.21 ± 0.93 21.81 ± 1.01 21.19 ± 1.05
Perirenal adipose, g/100 g BW 0.31 ± 0.04 0.34 ± 0.02 0.32 ± 0.03 0.29 ± 0.04 0.24 ± 0.03*
Epididymal adipose, g/100 g BW 0.67 ± 0.04 0.78 ± 0.03# 0.82 ± 0.04 0.78 ± 0.05 0.73 ± 0.06
Liver weight, g/100 g BW 3.83 ± 0.05 4.37 ± 0.18## 4.39 ± 0.11 4.28 ± 0.07 4.39 ± 0.11
Data were given as mean ± standard error of the mean of seven rats. # P < 0.05, # # P < 0.01 different from the control group; * P < 0.05 different from the
OA-fed group.
Rats were fed experimental diets for 10 d.
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mRNA (P < 0.05), and a 2.0-fold induction of G6PDH
(P < 0.05). Meanwhile, OA increased ME expression but
with no significant difference compared with control
group. SSC at 0.05% prevented the OA-induced stimula-
tion in SREBP-1c (P < 0.01) together with its response
gene. FAS, ME and G6PDH mRNA expression was
downregulated by SSC treatment, with a decrease of
20.1% (P < 0.05), 33.9% (P < 0.05) and 26.7% (P < 0.05)
separately (Figure 3).
Relative mRNA concentrations of PPARa and its target
genes inthe liver
Nonetheless, the reduction of hepatic lipids by SSC
could also be a result of an increase mRNA expression
in fatty acid b-oxidation. Therefore, we investigated the
expression of PPARa and its target gene, CPT-1, CPT-2
and ACO in the liver. The PPARa mRNA level was
unchanged between C and OA group, however 0.05%
SSC could enhance PPARa mRNA level by 1.37-fold
(P < 0.05). CPT-1 and CPT-2 showed the same pattern.
CPT-1and CPT-2 expression was inhibited by OA
administration (P < 0.05), and both was stimulated with
0.05% dietary SSC treatment (P < 0.05). ACO, a critical
enzyme required for peroxisomal b-oxidation, its expres-
sion showed no significant difference in control and OA
group, whereas it was much higher in SSC-treated
group (45.3%, P < 0.05) (Figure 4).
Discussion
It is clearly established that OA administration induces
fatty liver. Previous studies have demonstrated that
hepatic TG accumulation in rats fed OA as a result of
stimulated lipogensis [22,23] and impaired fatty acid cat-
abolism [24]. As we know, the liver plays a central role
in lipids metabolism and likely contribute to the onset
and progression of several chronic diseases, including
atherosclerosis, diabetes, and obesity. Because of the
high increasing prevalence of NAFLD in the world, it is
important to discover nutrients that will prevent the
development of NAFLD.
In the present study, the results showed that 1% OA-
supplement diet induced fatty liver in rats as previous
studies reported, with a concomitant significant increase
in serum TG concentration. And more excitedly, we
Table 4 The effect of SSC on serum and hepatic lipids in rats
Con OA OA+0.01% OA+0.03% OA+0.05%
Serum lipids
TC, mmol/L 1.98 ± 0.09 2.15 ± 0.10 1.88 ± 0.12 1.64 ± 0.11** 1.57 ± 0.14**
TG, mmol/L 0.39 ± 0.01 0.57 ± 0.06## 0.47 ± 0.03 0.42 ± 0.05* 0.36 ± 0.02**
Hepatic lipids
TC, mg/g 3.22 ± 0.12 5.50 ± 0.55## 4.37 ± 0.49 3.99 ± 0.36** 4.14 ± 0.34*
TG, mg/g 6.16 ± 0.65 43.97 ± 3.19## 30.11 ± 5.47* 17.02 ± 4.40** 18.73 ± 4.79**
PL, mg/g 31.20 ± 0.67 30.13 ± 0.43 28.99 ± 0.73 28.99 ± 0.73 29.51 ± 0.73
Data were given as mean ± standard error of the mean of seven rats. # P < 0.05, ## P < 0.01 different from the control group; * P < 0.05, **P < 0.05 different
from the OA-fed group.
Rats were fed experimental diets for 10 d.




























































































Figure 1 Effects of SSC on hepatic enzymes activities involved in fatty acid biosynthesis in rats. The hepatic enzymes activities of FAS, ME
and G6PDH in rats fed Con or OA diet or the diet with OA+0.05% SSC for 10 d. Data were given as mean ± standard error of the mean of
seven rats. # P < 0.05, ## P < 0.01 different from the control group; * P < 0.05 different from the OA-fed group.
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found that SSC could markedly reduced hepatic lipids
accumulation in the fatty liver rats, as well as serum TG
and TC concentration. The rats exhibited slight decrease
tendency in both serum TG and TC, even if fed at
0.01% SSC; when added 0.03% and 0.05% SSC, the rats
had much lower lipids level in serum. It is suggested
that dietary SSC could reduce serum lipids in a dose-
response manner.
The primary metabolic cause of lipid accumulation in
the liver is not well understood, but it could potentially
result from alterations in lipogenesis. Some key enzymes
involved in fatty acid biosynthesis were measured in this
study. FAS, a critical enzyme required for fatty acid de
novo synthesis, showed an increased activity in rats feed
OA diet. In addition, the activities of ME and G6PDH,
which provide NADPH required for FAS, were acceler-
ated by OA administration. The finding is consistent
with the report of Buang et al. [23], in which the lipo-
genic enzymes activities were higher. The present study
demonstrated that SSC suppressed all of those lipogenic

































Figure 2 Effects of SSC on hepatic CPT activity in rats. The
hepatic CPT activity in rats fed Con or OA diet or the diet with OA
+0.05% SSC for 10 d. Data were given as mean ± standard error of
the mean of seven rats. # P < 0.05 different from the control group;



































































































































































Figure 3 Effects of SSC on hepatic mRNA expression of lipogenic genes in rats. The expression of hepatic SREBP-1C, FAS, ME and G6PDH
in rats fed Con or OA diet or the diet with OA+0.05% SSC for 10 d. Data were given as mean ± standard error of the mean of seven rats.
# P < 0.05, ## P < 0.01 different from the control group; * P < 0.05, **P < 0.05 different from the OA-fed group.
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hepatic endogenous fatty acid synthesis may partly
explain why SSC alleviated fatty liver.
SREBP-1c is a member of the family of SREBP mem-
brane-bound transcription factors. It activates mainly
the transcription of lipogenic genes that contain sterol-
regulatory elements in their promoter regions, such as
FAS, G6PHD, ME [25,26]. SREBP-1c plays a major role
in the pathogenesis of NAFLD, as suggested in many
studies. Overexpression of SREBP-1c produces a pro-
nounced elevation of hepatic TG concentrations leading
to the development of NAFLD [27-29]. Hence, it is sug-
gested to suppress SREBP-1c expression in liver may
reduce the TG accumulation. Shrestha et al. showed
that dietary catechins extracted from green tea extract
could reduce plasma and hepatic TG concentration in
fructose-fed rats, mainly through downregulation of
SREBP-1c and its target gene [30]. Interestingly, we
found that the SREBP-1c mRNA expression was stimu-
lated by OA treatment, and consumption of SSC
suppressed its expression. As a result of the low SREBP-
1c expression in rats fed SSC, there was a concomitant
significant reduction in the expression of FAS, ME and
G6PDH mRNA. The results suggested that the stimu-
lated FAS, ME and G6PDH transcription may occur
after SREBP-1c activation caused by OA. SSC is likely to
have direct inhibitory effect on the SREBP-1c expres-
sion, which in turn influences these lipogenic genes
transcriptions, thereby reduces enzymes activity, result-
ing in a low rate of lipid synthesis.
Nonetheless, the accumulation of hepatic lipids by OA
could also be the result of a decrease in fatty acid b-oxi-
dation. Fatty acid b-oxidation takes place in two cellular
organelles: mitochondria and peroxisome [31]. It should
be emphasized that mitochondria is the quantitatively
dominating organelle in liver cells, proposing that mito-
chondrial oxidation might have the largest impact on
the total b-oxidation [32]. Since CPT is a rate-limiting































































































































































Figure 4 Effects of SSC on hepatic mRNA expression of lipolytic genes in rats. The expression of hepatic PPARa, CPT-1, CPT-2 and ACO in
rats fed Con or OA diet or the diet with OA+0.05% SSC for 10 d. Data were given as mean ± standard error of the mean of seven rats.
# P < 0.05 different from the control group; * P < 0.05, different from the OA-fed group.
Hu et al. Lipids in Health and Disease 2010, 9:25
http://www.lipidworld.com/content/9/1/25
Page 7 of 9
activity to reflect b-oxidation activity. And the results
showed that OA group rats decreased the b-oxidation
capacity of the liver, in agreement with the report of
Miyazawa [24]. Dietary SSC increased the hepatic CPT
activity by approximately 60%, suggesting an enhance-
ment of b-oxidation. This may contribute to a reduction
of hepatic TG deposit and steatosis, because of the
reduced flux of fatty acid used for TG synthesis. It is
proposed to be one of the mechanisms associated with
hypolipidemic effect of SSC.
Since SSC could enhance fatty acid b-oxidation in the
liver, we evaluated mRNA expression related to b-oxida-
tion. CPT-1 and CPT-2 were chosen as markers of
mitochondria, because they are rate-limiting enzymes of
fatty acid b-oxidation and used to reflect mitochondria
oxidation activity. ACO was chosen as marker because
it is a point to control peroxisomal b-oxidation. As we
know, the b-oxidation of lipids in liver could be regu-
lated by different transcription factors. PPARa is
thought to be the principal regulator in the fatty acid
oxidation. It is highly expressed in tissues obtaining a
high level of fatty acid catabolism, such as liver, brown
fat, heart, and skeletal muscle [33-35]. PPARa agonists,
such as fibrates, have been used for many years for
treating dyslipidemia, mainly due to their actions of low-
ering TG levels [36]. Recently, Huang et al. reported
that Salacia oblonga extract actions as a PPARa activa-
tor to improve hepatic steatosis in obese Zucker rats
[37]. To explore whether the hypolipidemic effect of
SSC was related to PPARa activation, mRNA expression
of PPARa and its response gene were measured using
realtime PCR. In the present study, PPARa mRNA
expression is significantly up-regulated by SSC treat-
ment, as well as CPT-1, CPT-2 and ACO mRNA. The
same trend among these genes suggested that SSC
enhanced fatty acid b-oxidation in liver via the pathway
of PPARa-mediated gene transcription. The upregula-
tion of gene expression leads to the increased b-oxida-
tion activity.
Conclusions
In summary, this study, using an OA-induced fatty liver
model, provides evidence that SSC significantly alle-
viated hepatic steatosis and reduced serum TG level.
Evidence from animal studies indicates that saponins
extracted from a variety of plant sources have lipids
lowering effects, such as ginseng, green tea and so on
[38-41]. It should be pointed that, saponins used in the
current study were prepared from sea cucumber,
belongs to the Echinodermata phylum. To our knowl-
edge, this is the first report on the hypolipidmic effect
of saponins derived from marine animals. Our findings
demonstrated that improvement of fatty liver by SSC
may be through the enhancement of PPARa-mediated
b-oxidation. On the other hand, reduction of hepatic
lipid accumulation was associated with a SREBP-1c-
mediated lipogenesis pathway.
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